Literature DB >> 27957225

What Does The Blanking Period Blank?

M A Mariani1, A Pozzoli2, Ge De Maat1, O R Alfieri3, S Benussi1.   

Abstract

In the management of paroxysmal, drug-refractory atrial fibrillation, pulmonary vein isolation has become a widely accepted treatment option. Currently, the arrhythmias following any form of myocardial ablation are not considered within a period of three months, known as "the blanking period". Although this period is authority- rather than evidence-based, it has become universally recognized. Indeed, several mechanisms play a role to determine the transient increased risk of post-procedural atrial tachyarrhythmias, occurring early after the procedure. Acute inflammatory changes may be responsible for immediate recurrence, since application of ablative energy on atrial tissue has a pro-inflammatory- and potentially arrhythmogenic effect. Atrial arrhythmias within the first 3 months after ablation are very common (35% to 65% of cases) and their significance as predictor of late recurrences is more significant during the first month. Furthermore, the current biological evidences indicate that the edema of the surrounding and ablated tissue is no longer present after 1 month. In our letter we advocate the reasons why a blanking period of four weeks should appear more reasonable, fostering its clinical importance and utility.

Entities:  

Keywords:  Ablative Therapy; Atrial Fibrillation; Blanking Period; Pulmonary Veins Isolation

Year:  2015        PMID: 27957225      PMCID: PMC5135184          DOI: 10.4022/jafib.1268

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  13 in total

1.  Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence.

Authors:  Gerhard Hindricks; Christopher Piorkowski; Hildegard Tanner; Richard Kobza; Jin-Hong Gerds-Li; Corrado Carbucicchio; Hans Kottkamp
Journal:  Circulation       Date:  2005-07-11       Impact factor: 29.690

2.  Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation.

Authors:  Bernhard Richter; Marianne Gwechenberger; Ariel Socas; Gerlinde Zorn; Sulaima Albinni; Manfred Marx; Jutta Bergler-Klein; Thomas Binder; Johann Wojta; Heinz D Gössinger
Journal:  Clin Res Cardiol       Date:  2011-11-19       Impact factor: 5.460

3.  Cardiac swelling associated with linear radiofrequency ablation in the atrium.

Authors:  D Schwartzman; J F Ren; W A Devine; D J Callans
Journal:  J Interv Card Electrophysiol       Date:  2001-06       Impact factor: 1.900

4.  Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation.

Authors:  Hakan Oral; Bradley P Knight; Mehmet Ozaydin; Hiroshi Tada; Aman Chugh; Sohail Hassan; Christoph Scharf; Steve W K Lai; Radmira Greenstein; Frank Pelosi; S Adam Strickberger; Fred Morady
Journal:  J Am Coll Cardiol       Date:  2002-07-03       Impact factor: 24.094

5.  Five-year experience with the maze procedure for atrial fibrillation.

Authors:  J L Cox; J P Boineau; R B Schuessler; K M Kater; D G Lappas
Journal:  Ann Thorac Surg       Date:  1993-10       Impact factor: 4.330

6.  Comparison of characteristics and significance of immediate versus early versus no recurrence of atrial fibrillation after catheter ablation.

Authors:  Takashi Koyama; Yukio Sekiguchi; Hiroshi Tada; Takanori Arimoto; Hiro Yamasaki; Kenji Kuroki; Takeshi Machino; Kazuko Tajiri; Xu Dong Zhu; Miyako Kanemoto; Aiko Sugiyasu; Keisuke Kuga; Kazutaka Aonuma
Journal:  Am J Cardiol       Date:  2009-03-09       Impact factor: 2.778

7.  Prevalence and severity of left atrial edema detected by electron beam tomography early after pulmonary vein ablation.

Authors:  Taro Okada; Takumi Yamada; Yoshimasa Murakami; Naoki Yoshida; Yuuichi Ninomiya; Takeshi Shimizu; Junji Toyama; Yukihiko Yoshida; Teruo Ito; Naoya Tsuboi; Takahisa Kondo; Yasuya Inden; Makoto Hirai; Toyoaki Murohara
Journal:  J Am Coll Cardiol       Date:  2007-03-21       Impact factor: 24.094

8.  Prevalence, predictors, and prognosis of atrial fibrillation early after pulmonary vein isolation: findings from 3 months of continuous automatic ECG loop recordings.

Authors:  Sandeep Joshi; Andrew D Choi; Ganesh S Kamath; Farbod Raiszadeh; Daniel Marrero; Apurva Badheka; Suneet Mittal; Jonathan S Steinberg
Journal:  J Cardiovasc Electrophysiol       Date:  2009-06-22

9.  Clinical predictors and relationship between early and late atrial tachyarrhythmias after pulmonary vein antrum isolation.

Authors:  Sakis Themistoclakis; Robert A Schweikert; Walid I Saliba; Aldo Bonso; Antonio Rossillo; Giovanni Bader; Oussama Wazni; David J Burkhardt; Antonio Raviele; Andrea Natale
Journal:  Heart Rhythm       Date:  2008-01-30       Impact factor: 6.343

10.  Frequency of recurrence of atrial fibrillation within 48 hours after ablation and its impact on long-term outcome.

Authors:  Bernhard Richter; Marianne Gwechenberger; Ariel Socas; Manfred Marx; Heinz David Gössinger
Journal:  Am J Cardiol       Date:  2008-01-18       Impact factor: 2.778

View more
  1 in total

1.  Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: iHEART results.

Authors:  Isaac L Goldenthal; Robert R Sciacca; Teresa Riga; Suzanne Bakken; Maurita Baumeister; Angelo B Biviano; Jose M Dizon; Daniel Wang; Ketty C Wang; William Whang; Kathleen T Hickey; Hasan Garan
Journal:  J Cardiovasc Electrophysiol       Date:  2019-09-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.